Literature DB >> 12841339

Correlation between the extent of coronary atherosclerosis and lipid profile.

Janusz Tarchalski1, Przemysław Guzik, Henryk Wysocki.   

Abstract

Increased concentration of low density lipoprotein (LDL) cholesterol or decreased level of high density lipoprotein (HDL) cholesterol are important risk factors for coronary atherosclerosis. However, an independent association of triglycerides (TG) with atherosclerosis is uncertain. The aim of this prospective study was to evaluate the relationship between serum lipid levels and the extent of coronary atherosclerosis in patients with suspected coronary artery disease (CAD) and no previous myocardial infarction who were not treated with lipids lowering therapy or low-lipid diet. The study was conducted in 141 patients (53.6 +/- 7.8 years old; 32 female) who underwent a routine coronary angiography for CAD diagnosis. A modified angiographic Gensini Score (GS) was used to reflect the extent of coronary atherosclerosis. Fasting serum lipid concentrations were determined using cholesterol esterase/peroxidase (CHOD/PAP) enzymatic method for total cholesterol and its fractions and lipase glycerol kinase (GPO/PAP) enzymatic method TG evaluation. The association of Gensini Score with variables characterising lipid profile was analysed with the use of Pearson correlation (r co-efficient; p value). GS was positively correlated with total cholesterol (r = 0.404; p < 0.001), LDL cholesterol (r = 0.484; p < 0.001 ) and TG (r = 0.235; p = 0.005). There was a negative correlation between Gensini Score and HDL cholesterol (r = -0.396; p < 0.001). In angina pectoris patients with no previous myocardial infarction, the extent of coronary atherosclerosis is positively correlated with pro-atherogenic lipids, i.e. total cholesterol, LDL cholesterol and TG and negatively correlated with antiatherogenic HDL cholesterol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841339

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

Review 1.  Hyperlipidemia: diagnostic and therapeutic perspectives.

Authors:  C M Ballantyne; S M Grundy; A Oberman; R A Kreisberg; R J Havel; P H Frost; S M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

2.  Role of novel markers of inflammation in patients with stable coronary heart disease.

Authors:  A Hoffmeister; D Rothenbacher; U Bäzner; M Fröhlich; H Brenner; V Hombach; W Koenig
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

4.  Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function.

Authors:  L Y Chen; P Mehta; J L Mehta
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

5.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Triglyceride concentration and coronary heart disease.

Authors:  A M Garber; A L Avins
Journal:  BMJ       Date:  1994-07-02

7.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

8.  Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis.

Authors:  J P Lekakis; C M Papamichael; A T Cimponeriu; K S Stamatelopoulos; T G Papaioannou; J Kanakakis; M K Alevizaki; A Papapanagiotou; A T Kalofoutis; S F Stamatelopoulos
Journal:  Am J Cardiol       Date:  2000-04-15       Impact factor: 2.778

Review 9.  Role of insulin resistance in human disease (syndrome X): an expanded definition.

Authors:  G M Reaven
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  14 in total

1.  Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.

Authors:  Asad Vaisi-Raygani; Hori Ghaneialvar; Zohreh Rahimi; Haidar Tavilani; Tayebeh Pourmotabbed; Ebrahim Shakiba; Aliakbar Vaisi-Raygani; Amir Kiani; Mahdi Aminian; Reza Alibakhshi; Cynthia Bartels
Journal:  Mol Biol Rep       Date:  2011-04-05       Impact factor: 2.316

2.  Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort.

Authors:  Romy de Laat-Kremers; Augusto Di Castelnuovo; Lisa van der Vorm; Simona Costanzo; Marisa Ninivaggi; Chiara Cerletti; Dana Huskens; Amalia De Curtis; Alessandro Gialluisi; Cuicui Bai; Giovanni de Gaetano; Dongmei Yin; Maria Benedetta Donati; Bas de Laat; Licia Iacoviello
Journal:  Front Cardiovasc Med       Date:  2022-06-16

3.  Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients.

Authors:  B K Manjunatha Goud; Bhavna Nayal; Oinam S Devi; R N Devaki; S S Avinash; T G Satisha; C V Raghuveer
Journal:  J Cardiovasc Dis Res       Date:  2012-10

4.  Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.

Authors:  Liqun Ren; Naifeng Liu; Hong Zhi; Yingjuan Li; Yanzhi Li; Rining Tang; Zulong Sheng
Journal:  Cardiovasc Diabetol       Date:  2011-01-26       Impact factor: 9.951

5.  High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients.

Authors:  Ki-Bum Won; Hyuk-Jae Chang; Sung-Ha Park; Sung-Yu Hong; Yangsoo Jang; Namsik Chung
Journal:  Korean Circ J       Date:  2012-05-24       Impact factor: 3.243

6.  Correlated functional connectivity and glucose metabolism in brain white matter revealed by simultaneous MRI/positron emission tomography.

Authors:  Bin Guo; Fugen Zhou; Muwei Li; John C Gore; Zhaohua Ding
Journal:  Magn Reson Med       Date:  2021-11-26       Impact factor: 3.737

7.  Association of lipid profile test values, type-2 diabetes mellitus, and periodontitis.

Authors:  D S Kalsi; Jyoti Chopra; Anchal Sood
Journal:  Indian J Dent       Date:  2015 Apr-Jun

8.  Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients.

Authors:  Samia Hadj Ahmed; Nadia Kaoubaa; Wafa Kharroubi; Amira Zarrouk; Mohamed Fadhel Najjar; Fathi Batbout; Habib Gamra; Gerard Lizard; Mohamed Hammami
Journal:  Lipids Health Dis       Date:  2017-08-14       Impact factor: 3.876

9.  Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients.

Authors:  Vasileios Peppes; George Rammos; Efstathios Manios; Eleni Koroboki; Stylianos Rokas; Nikolaos Zakopoulos
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Effects and mechanism of Xin Mai Jia in a rabbit model of atherosclerosis.

Authors:  Fan-Rong Zhao; Jun-Xiu Lu; Mei Jia; Ya-Ling Yin; Heng-Tian Qi; Mo-Li Zhu; Li-Juan Ma; LE-LE Qiu; Guang-Ming Wan; Guang-Rui Wan
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.